AI-generated content for informational purposes only. Not financial advice. Always do your own research.

About

UnitedHealth Group (NYSE: UNH) is the largest healthcare company in the world by revenue and the most valuable health stock by market capitalization, operating through two main divisions: UnitedHealthcare, the nation's largest health insurance provider covering over 50 million members, and Optum, a diversified health services business spanning pharmacy benefits, care delivery, and data analytics. The Optum segment has been a key growth engine, expanding into direct healthcare delivery through physician practices, ambulatory surgery centers, and home health services, creating a vertically integrated healthcare enterprise. UnitedHealth Group is a dominant healthcare investment offering exposure to the full spectrum of health services, with a proven management team, consistent double-digit earnings growth, and a track record of increasing dividends for over a decade.

Aging Population Stocks

UnitedHealth Group is the world's largest healthcare company, combining the nation's biggest health insurer (UnitedHealthcare) with Optum's healthcare services, directly benefiting from aging population dynamics.

Healthcare Stocks

UnitedHealth Group is the largest healthcare stock by both revenue and market capitalization, combining the nation's biggest health insurance operation with the rapidly growing Optum health services platform to create a vertically integrated healthcare enterprise that touches nearly every aspect of the U.S. healthcare system.

Key Financials UNH

Price $293.19
Change (1D) +3.10%
Change (30D) -11.18%
Change (60D) -8.53%
Change (90D) -18.28%
Change (180D) -1.65%
Change (1Y) -44.41%
Change (5Y) -11.05%
P/E Ratio 13.20
EPS (TTM) $22.21
52-Week Range $234.60 โ€” $606.36
50-Day MA $321.23
Volume 10.27M

Data updated Feb 15 ยท Source: Twelve Data

4.1 2 reviews

AI Reviews

๐Ÿค–
3.7 /5
UnitedHealth Group, the nation's largest health insurer and parent of Optum's healthcare services empire, has experienced a dramatic decline " down over 44% in the past year from its 52-week high of $606. The sell-off reflects a convergence of headwinds: rising medical costs, regulatory scrutiny, a DOJ investigation, and the tragic shooting of a subsidiary CEO that intensified public backlash against managed care. At a P/E of 13.2x with EPS of $22.21, the stock trades at a significant discount to historical multiples, potentially offering deep value for patient investors. The bull case centers on UNH's dominant market position in Medicare Advantage (directly benefiting from aging demographics), diversified revenue streams through Optum, and a track record of consistent earnings growth. The bear case includes elevated medical loss ratios, political risk around healthcare reform, potential regulatory actions, and questions about whether management can restore credibility. Trading well below its 50-day moving average of $321, momentum remains decidedly negative. However, UNH's structural advantages in serving an aging population and its integrated care model provide a durable competitive moat that makes this selloff worth monitoring closely.

Category Ratings

Aging Population Stocks
3.8
Healthcare Stocks
3.5
Feb 15, 2026
AI-Generated Review Generated via Anthropic API. This is an automated evaluation, not a consumer review. Learn more
๐Ÿค–
4.4 /5
UnitedHealth Group remains a dominant force in the healthcare sector, leveraging its integrated model of insurance (UnitedHealthcare) and health services (Optum) to drive long-term growth. The provided financial data indicates the stock is currently trading at a P/E ratio of 12.30, a valuation that appears remarkably attractive relative to historical norms for such a high-quality compounder. While the share price has retreated significantly from its 52-week high of $606.36, creating a bearish technical setup below the 50-day moving average, the company's earnings power remains resilient with an EPS of $22.21. Investors must weigh the attractive valuation against risks like regulatory scrutiny on Medicare Advantage and rising medical loss ratios. However, for value-oriented investors, UNH presents a potential opportunity to acquire a sector leader at a discounted multiple.

Category Ratings

Healthcare Stocks
4.4
Feb 11, 2026
AI-Generated Review Generated via Google API. This is an automated evaluation, not a consumer review. Learn more
UnitedHealth Group Screenshot

Added: Feb 10, 2026

unitedhealthgroup.com